Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Who benefits from granulomas, mycobacteria or host?

Literature DB >> 19135882

Who benefits from granulomas, mycobacteria or host?

Abstract

By investigating host-pathogen interactions in zebrafish using intravital imaging, Davis and Ramakrishnan (2009) provide evidence that aggregates of immune cells known as granulomas, long thought to constrain mycobacterial infection, may instead facilitate its spread.

Entities: Chemical Disease Species

Mesh：

Year: 2009 PMID： 19135882 PMCID： PMC4214211 DOI： 10.1016/j.cell.2008.12.032

Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582

8 in total

1. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.

Authors: Joseph Hinchey; Sunhee Lee; Bo Y Jeon; Randall J Basaraba; Manjunatha M Venkataswamy; Bing Chen; John Chan; Miriam Braunstein; Ian M Orme; Steven C Derrick; Sheldon L Morris; William R Jacobs; Steven A Porcelli
Journal: J Clin Invest Date: 2007-08 Impact factor: 14.808

2. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors: Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal: Immunity Date: 2008-08-15 Impact factor: 31.745

3. The granulomatous inflammatory response. A review.

Authors: D O Adams
Journal: Am J Pathol Date: 1976-07 Impact factor: 4.307

4. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos.

Authors: J Muse Davis; Hilary Clay; Jessica L Lewis; Nafisa Ghori; Philippe Herbomel; Lalita Ramakrishnan
Journal: Immunity Date: 2002-12 Impact factor: 31.745

5. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas.

Authors: Jackson G Egen; Antonio Gigliotti Rothfuchs; Carl G Feng; Nathalie Winter; Alan Sher; Ronald N Germain
Journal: Immunity Date: 2008-02-07 Impact factor: 31.745

Review 6. Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis.

Authors: Joel D Ernst; Giraldina Trevejo-Nuñez; Niaz Banaiee
Journal: J Clin Invest Date: 2007-07 Impact factor: 14.808

7. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.

Authors: Andrea J Wolf; Ludovic Desvignes; Beth Linas; Niaz Banaiee; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal: J Exp Med Date: 2007-12-24 Impact factor: 14.307

8. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells.

Authors: Kamalakannan Velmurugan; Bing Chen; Jessica L Miller; Sharon Azogue; Serdar Gurses; Tsungda Hsu; Michael Glickman; William R Jacobs; Steven A Porcelli; Volker Briken
Journal: PLoS Pathog Date: 2007-07 Impact factor: 6.823

8 in total

29 in total

1. Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors: Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal: Infect Immun Date: 2014-11-03 Impact factor: 3.441

2. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo.

Authors: Prachi P Singh; Victoria L Smith; Petros C Karakousis; Jeffery S Schorey
Journal: J Immunol Date: 2012-06-20 Impact factor: 5.422

3. Indoleamine 2,3-dioxygenase, tryptophan catabolism, and Mycobacterium avium subsp. paratuberculosis: a model for chronic mycobacterial infections.

Authors: Karren M Plain; Kumudika de Silva; John Earl; Douglas J Begg; Auriol C Purdie; Richard J Whittington
Journal: Infect Immun Date: 2011-07-05 Impact factor: 3.441

4. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

Authors: Lis R V Antonelli; Antonio Gigliotti Rothfuchs; Ricardo Gonçalves; Ester Roffê; Allen W Cheever; Andre Bafica; Andres M Salazar; Carl G Feng; Alan Sher
Journal: J Clin Invest Date: 2010-04-12 Impact factor: 14.808

5. Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.

Authors: Shen-An Hwang; Kerry J Welsh; Sydney Boyd; Marian L Kruzel; Jeffrey K Actor
Journal: Tuberculosis (Edinb) Date: 2011-11-15 Impact factor: 3.131

6. Hesperidin methyl chalcone alleviates spinal tuberculosis in New Zealand white rabbits by suppressing immune responses.

Authors: Yi Zhao; Yong Jiao; Lei Wang
Journal: J Spinal Cord Med Date: 2018-08-20 Impact factor: 1.985

7. Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment.

Authors: Christopher R Shaler; Kapilan Kugathasan; Sarah McCormick; Daniela Damjanovic; Carly Horvath; Cherrie-Lee Small; Mangalakumari Jeyanathan; Xiao Chen; Ping-Chang Yang; Zhou Xing
Journal: Am J Pathol Date: 2011-04 Impact factor: 4.307

Review 8. The pregnane X receptor in tuberculosis therapeutics.

Authors: Amina I Shehu; Guangming Li; Wen Xie; Xiaochao Ma
Journal: Expert Opin Drug Metab Toxicol Date: 2015-12-05 Impact factor: 4.481

9. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection.

Authors: Toshihiro Masaki; Jinrong Qu; Justyna Cholewa-Waclaw; Karen Burr; Ryan Raaum; Anura Rambukkana
Journal: Cell Date: 2013-01-17 Impact factor: 41.582

10. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.

Authors: María A Duque-Correa; Anja A Kühl; Paulo C Rodriguez; Ulrike Zedler; Sandra Schommer-Leitner; Martin Rao; January Weiner; Robert Hurwitz; Joseph E Qualls; George A Kosmiadi; Peter J Murray; Stefan H E Kaufmann; Stephen T Reece
Journal: Proc Natl Acad Sci U S A Date: 2014-09-08 Impact factor: 11.205